TRILOGY ACETABULAR STANDARD LINER
Report
- Report Number
- 1822565-2011-00718
- Event Type
- Injury
- Date Received
- March 23, 2011
- Date of Event
- February 16, 2011
- Report Date
- February 24, 2011
- Manufacturer
- ZIMMER INC
- Product Code
- LPH
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- PHYSICIAN
Narratives
INFORMATION WAS RECEIVED FROM A HEALTH PROFESSIONAL WHO IS NOT REQUIRED TO COMPLETE FORM 3500A. EVALUATION SUMMARY: SURGICAL NOTES OF BOTH THE PRIMARY AND REVISION SURGERIES WERE REVIEWED, BUT DID NOT EXHIBIT ANY COMPLICATIONS. THE REVISION OP NOTES INDICATED THAT THE SURGEON REMOVED SOME OSTEOLYTIC DEBRIS FROM THE JOINT SITE. X-RAYS WERE NOT PROVIDED; IT IS UNK WHETHER THE COMPONENTS WERE IMPLANTED WITH THE CORRECT FIT AND ORIENTATION AS PER THE SURGICAL TECHNIQUE. THE ACTIVITY OF THE PT IS UNK. THE IMPLANTS WERE IN VIVO FOR 11.5 YEARS, SO IT IS REASONABLE TO ASSUME THAT THE DEVICE WILL EXHIBIT WEAR AS IT IS LOADED THROUGHOUT THE LIFETIME OF THE DEVICE. WITHOUT THE RETURN OF THE IMPLANTED DEVICES, X-RAYS, OR OTHER SUPPORTING INFORMATION, A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED. EVALUATION: THE MANUFACTURING RECORDS OF THE DEVICES IMPLANTED WERE REVIEWED AND FOUND TO BE CONFORMING INDICATING THAT THEY WERE MANUFACTURED, INSPECTED, AND PACKAGED TO SPECIFICATION. IT IS NOT SUSPECTED THAT THE PRODUCT FAILED TO MEET SPECIFICATIONS. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY EVIDENCE OF PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFORMATION BE RECEIVED, THE COMPLAINT WILL BE REOPENED. ZIMMER, INC. CONSIDERS THE INVESTIGATION CLOSED.
IT IS REPORTED THAT THE PT WAS REVISED DUE TO WEAR OF THE POLYETHYLENE LINER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TRILOGY ACETABULAR STANDARD LINER | LPH | ZIMMER INC | 60951200 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 35 YR | Required Intervention |